trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Sachs LM et al. An essential role of histone deacetylases in postembryonic organ transformations in Xenopus laevis. 2001 Int. J. Mol. Med. pmid:11712071
Lefevre P et al. Identification of factors mediating the developmental regulation of the early acting -3.9 kb chicken lysozyme enhancer element. 2001 Nucleic Acids Res. pmid:11713304
Sekita N et al. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. 2001 Jpn. J. Cancer Res. pmid:11572762
Yin L et al. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. 2001 J. Biol. Chem. pmid:11572859
Leng SL et al. Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. 2001 Carcinogenesis pmid:11577001
Yang X et al. Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. 2001 Cancer Res. pmid:11585728
Abderrahmani A et al. The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1). 2001 Mol. Cell. Biol. pmid:11585908
Yoshida M et al. Histone deacetylase as a new target for cancer chemotherapy. 2001 Cancer Chemother. Pharmacol. pmid:11587361
Jung M Inhibitors of histone deacetylase as new anticancer agents. 2001 Curr. Med. Chem. pmid:11562279
Ashburner BP et al. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. 2001 Mol. Cell. Biol. pmid:11564889
Sachs LM et al. Involvement of histone deacetylase at two distinct steps in gene regulation during intestinal development in Xenopus laevis. 2001 Dev. Dyn. pmid:11668605
Amann JM et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. 2001 Mol. Cell. Biol. pmid:11533236
Walker GE et al. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. 2001 Endocrinology pmid:11517158
Jorgensen JS and Nilson JH AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2. 2001 Mol. Endocrinol. pmid:11518798
Phiel CJ et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. 2001 J. Biol. Chem. pmid:11473107
Sundqvist A et al. Functional knockout of the corepressor CtBP by the second exon of adenovirus E1a relieves repression of transcription. 2001 Exp. Cell Res. pmid:11478854
Jacob AL et al. Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. 2001 J. Biol. Chem. pmid:11479297
Sourlingas TG et al. Histone deacetylase inhibitors induce apoptosis in peripheral blood lymphocytes along with histone H4 acetylation and the expression of the linker histone variant, H1 degrees. 2001 Eur. J. Cell Biol. pmid:11824792
Benjamin D and Jost JP Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. 2001 Nucleic Acids Res. pmid:11522830
Li J et al. Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation. 2001 Mol. Cell. Biol. pmid:11689710
Hirschler-Laszkiewicz I et al. The role of acetylation in rDNA transcription. 2001 Nucleic Acids Res. pmid:11600700
Nair AR et al. Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. 2001 Cancer Lett. pmid:11295287
Hatama S et al. Reactivation of feline foamy virus from a chronically infected feline renal cell line by trichostatin A. 2001 Virology pmid:11336556
Viollet B et al. Embryonic but not postnatal reexpression of hepatocyte nuclear factor 1alpha (HNF1alpha) can reactivate the silent phenylalanine hydroxylase gene in HNF1alpha-deficient hepatocytes. 2001 Mol. Cell. Biol. pmid:11340160
Nakamura M et al. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor. 2001 J. Cell. Physiol. pmid:11319763
Xu D et al. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11274400
Seth KA and Majzoub JA Repressor element silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. 2001 J. Biol. Chem. pmid:11278361
Rashid SF et al. Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. 2001 Oncogene pmid:11313934
Wang H et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. 2001 Science pmid:11387442
Klar AJ et al. A histone deacetylation inhibitor and mutant promote colony-type switching of the human pathogen Candida albicans. 2001 Genetics pmid:11404352
Massa S et al. 3-(4-aroyl-1H-pyrrol-2-yl)-N-hydroxy-2-propenamides, a new class of synthetic histone deacetylase inhibitors. 2001 J. Med. Chem. pmid:11405644
Setlow JK et al. Evidence for gene silencing in Haemophilus influenzae. 2001 Mutat. Res. pmid:11406170
Singal R et al. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. 2001 Cancer Res. pmid:11406558
Baur JA et al. Telomere position effect in human cells. 2001 Science pmid:11408657
Zelivianski S et al. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. 2001 Biochim. Biophys. Acta pmid:11389966
Harada Y et al. A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1. 2001 Biochem. Biophys. Res. Commun. pmid:11396961
Yang H et al. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11208539
Ullerås E et al. Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. 2001 Exp. Cell Res. pmid:11640883
Arthur JL et al. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. 2001 J. Virol. pmid:11264377
Furumai R et al. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11134513
Johnson CA et al. Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis. 2001 J. Biol. Chem. pmid:11136718
Griswold MD et al. Mechanisms involved in the homologous down-regulation of transcription of the follicle-stimulating hormone receptor gene in Sertoli cells. 2001 Mol. Cell. Endocrinol. pmid:11223181
Chang YC et al. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene. 2001 Mol. Cell. Biol. pmid:11158299
Newell-Price J et al. The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. 2001 Mol. Endocrinol. pmid:11158338
Kamitani H et al. Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. 2001 Carcinogenesis pmid:11159758
Shestakova E et al. Inhibition of histone deacetylation induces constitutive derepression of the beta interferon promoter and confers antiviral activity. 2001 J. Virol. pmid:11238870
Kuwahara K et al. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. 2001 Mol. Cell. Biol. pmid:11238943
Meier JL Reactivation of the human cytomegalovirus major immediate-early regulatory region and viral replication in embryonal NTera2 cells: role of trichostatin A, retinoic acid, and deletion of the 21-base-pair repeats and modulator. 2001 J. Virol. pmid:11160656
Kuusisto E et al. Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells. 2001 Biochem. Biophys. Res. Commun. pmid:11162503
Grandjean V et al. Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain. 2001 FEBS Lett. pmid:11163765